Abstract:AIM:To observe the therapeutic efficacy of high-dose Vitamin C (Vit. C) on acute pancreatitis (AP), and to explore its potential mechanisms.METHODS:Eighty-four AP patients were divided into treatment group and control group, 40 healthy subjects were taken as a normal group. In the treatment group, Vit. C (10 g/day) was given intravenously for 5 days, whereas in the control group, Vit. C (1 g/day) was given intravenously for 5 days. Symptoms, physical signs, duration of hospitalization, complications and mortality rate were monitored. Meanwhile, serum amylase, urine amylase and leukocyte counts were also determined. The concentration of plasma vitamin C (P-VC), plasma lipid peroxide (P-LPO), plasma vitamin E (P-VE), plasma beta-carotene (P-beta-CAR), whole blood glutathione (WB-GSH) and the activity of erythrocyte surperoxide dimutase (E-SOD) and erythrocyte catalase (E-CAT) as well as T lymphocyte phenotype were measured by spectrophotometry in the normal group and before and after treatment with Vit. C in the treatment and the control group.RESULTS:Compared with the normal group, the average values of P-VC, P-VE, P-beta-CAR, WB-GSH and the activity of E-SOD and E-CAT in AP patients were significantly decreased and the average value of P-LPO was significantly increased, especially in severe acute pancreatitis (SAP) patients (P<0.05. P-VC, P=0.045; P-VE, P=0.038; P=0.041; P-beta-CAR, P=0.046; WB-GSH, P=0.039; E-SOD, P=0.019; E-CAT, P=0.020; P-LPO, P=0.038). Compared with the normal group, CD3 and CD4 positive cells in AP patients were significantly decreased. The ratio of CD4/CD8 and CD4 positive cells were decreased, especially in SAP patients (P<0.05. CD4/CD8, P=0.041; CD4, P =0.019). Fever and vomiting disappeared, and leukocyte counts and amylase in urine and blood become normal quicker in the treatment group than in the control group. Moreover, patients in treatment group also had a higher cure rate, a lower complication rate and a shorter in-ward days compared with those in he control group. After treatment, the average value of P-VC was significantly higher and the values of SIL-2R, TNF-alpha, IL-6 and IL-8 were significantly lower in the treatment group than in the control group (P<0.05 P-VC, P=0.045; SIL-2R, P=0.012; TNF-alpha, P=0.030; IL-6, P=0.015; and IL-8, P=0.043). In addition, the ratio of CD4/CD8 and CD4 positive cells in the patients of treatment group were significantly higher than that of the control group after treatment (P<0.05. CD4/CD8, P=0.039; CD4, P=0.024).CONCLUSION:High-dose vitamin C has therapeutic efficacy on acute pancreatitis. The potential mechanisms include promotion of anti-oxidizing ability of AP patients, blocking of lipid peroxidation in the plasma and improvement of cellular immune function.

[Nuclear Factor-Kappab Expression in Peripheral Blood Polymorphonuclear Leukocytes of Patients with Acute Pancreatitis and the Preventive Effectiveness of Pyrrolidine Dithiocarbamate on NF-kappaB in Vitro].

Role of Nuclear Factor-Kappab, Reactive Oxygen Species and Cellular Signaling in the Early Phase of Acute Pancreatitis.

Study of the Protective Effects of Dexamethasone on Ileum Mucosa Injury in Rats with Severe Acute Pancreatitis.

Intraductal Administration of an NK1 Receptor Antagonist Attenuates the Inflammatory Response to Retrograde Infusion of Radiological Contrast in Rats: Implications for the Pathogenesis and Prevention of ERCP-induced Pancreatitis.

Inhibition of nuclear factor-κB activation improves the survival of rats with taurocholate pancreatitis

Potential Effects of PKC or Protease Inhibitors on Acute Pancreatitis-Induced Tissue Injury in Rats.

Protective Effect of Dexamethasone on the Kidneys of Rats with Severe Acute Pancreatitis and its Mechanism.

Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation

The Potential Effect Of Proteasome Inhibitor Ps-341 On Severe Acute Pancreatitis Detected By Positron Emission Tomography In Icr Mice

N-acetylcysteine Decreases the Severity of Pancreatic Injury in Rats with Acute Necrotizing Pancreatitis

The Expression of Nuclear Factor-kappa B in Pancreatic Tissue of Rats with Severe Acute Pancreatitis

Elimination of Intracellular Ca2+ Overload by BAPTA‑AM Liposome Nanoparticles: A Promising Treatment for Acute Pancreatitis

MARCH9, a potential target for the treatment of acute pancreatitis, inhibits NLRP3 inflammasome mediated pyroptosis

Tetramethylpyrazine (TMP) protects rats against acute pancreatitis through NF-κB pathway

Intervention of pyrrolidine dithiocarbamate and tetrandrine on cellular calcium overload of pancreatic acinar cells induced by serum and ascitic fluid from rats with acute pancreatitis.

PDTC attenuates radiation-induced heart damage by inhibiting the activation of NF-κB and its downstream signaling pathways in rats

Therapeutic Efficacy of High-Dose Vitamin C on Acute Pancreatitis and Its Potential Mechanisms

Effects of Baicalin on Inflammatory Reaction, Oxidative Stress and PKDl and NF-kB Protein Expressions in Rats with Severe Acute Pancreatitis

The Relationship Between Pancreatic Ischemia and Cytokines in Rats with Acute Pancreatitis

The Effect of Early Used High-Dose Vitamin C on NF-κB of Rats with Serious Acute Pancreatitis

Pyrrolidine Dithiocarbamate (PDTC) Inhibits DON-Induced Mitochondrial Dysfunction and Apoptosis via the NF-κB/iNOS Pathway